BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 18090265)

  • 21. Combining prevention, treatment and care: lessons from South Africa.
    Achmat Z; Simcock J
    AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
    Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
    Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [AIDS treatment in Africa: the risk of antiretroviral resistance].
    Hamers RL; Schuurman R; van Vugt M; Derdelinckx I; Rinke de Wit TF
    Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2666-71. PubMed ID: 18179083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.
    Souteyrand YP; Collard V; Moatti JP; Grubb I; Guerma T
    AIDS; 2008 Jul; 22 Suppl 1():S161-8. PubMed ID: 18664948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding community through ARV provision in Thailand.
    Lyttleton C; Beesey A; Sitthikriengkrai M
    AIDS Care; 2007; 19 Suppl 1():S44-53. PubMed ID: 17364387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenge and co-operation: civil society activism for access to HIV treatment in Thailand.
    Ford N; Wilson D; Cawthorne P; Kumphitak A; Kasi-Sedapan S; Kaetkaew S; Teemanka S; Donmon B; Preuanbuapan C
    Trop Med Int Health; 2009 Mar; 14(3):258-66. PubMed ID: 19207173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender asymmetry in healthcare-facility attendance of people living with HIV/AIDS in Burkina Faso.
    Bila B; Egrot M
    Soc Sci Med; 2009 Sep; 69(6):854-61. PubMed ID: 19539415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How do subjectively-constructed meanings ascribed to anti-HIV treatments affect treatment-adherent practice?
    Wong WK; Ussher J
    Qual Health Res; 2008 Apr; 18(4):458-68. PubMed ID: 18354045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with adherence to antiretroviral therapy for the treatment of HIV-infected women attending an urban care facility.
    Aspeling HE; van Wyk NC
    Int J Nurs Pract; 2008 Feb; 14(1):3-10. PubMed ID: 18190478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Life projects and therapeutic itineraries: marriage, fertility, and antiretroviral therapy in Nigeria.
    Smith DJ; Mbakwem BC
    AIDS; 2007 Oct; 21 Suppl 5():S37-41. PubMed ID: 18090266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'.
    Harries AD; Makombe SD; Schouten EJ; Ben-Smith A; Jahn A
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):310-1. PubMed ID: 18316103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adherence to antiretroviral therapy during HIV infection, a multidisciplinary approach].
    Slama L; Le Camus C; Amiel C; Pialoux G; Gharakhanian S
    Med Mal Infect; 2006 Jan; 36(1):16-26. PubMed ID: 16325363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human right to health, national courts, and access to HIV/AIDS treatment: a case study from Venezuela.
    Torres MA
    Chic J Int Law; 2002; 3(1):105-14. PubMed ID: 15709302
    [No Abstract]   [Full Text] [Related]  

  • 36. Stigma and social barriers to medication adherence with urban youth living with HIV.
    Rao D; Kekwaletswe TC; Hosek S; Martinez J; Rodriguez F
    AIDS Care; 2007 Jan; 19(1):28-33. PubMed ID: 17129855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time, self and the medication day: a closer look at the everyday work of 'adherence'.
    McCoy L
    Sociol Health Illn; 2009 Jan; 31(1):128-46. PubMed ID: 19170973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretrovirals: reality or illusion?
    Mazin R; Zacarias F
    J Int Assoc Physicians AIDS Care; 1998 Oct; 4(10):28-9. PubMed ID: 11365958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of barriers and facilitators of HIV treatment among injection drug users.
    Wood E; Kerr T; Tyndall MW; Montaner JS
    AIDS; 2008 Jul; 22(11):1247-56. PubMed ID: 18580603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive clinical adherence interventions to enable antiretroviral therapy: a case report.
    Nicca D; Moody K; Elzi L; Spirig R
    J Assoc Nurses AIDS Care; 2007; 18(6):44-53. PubMed ID: 17991598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.